Ozempic and Mounjaro are only FDA-approved to treat type 2 diabetes
Reduces Risk of Cardiovascular Events Shown to lower the risk of heart attacks, strokes, and cardiovascular death, similar to semaglutide, by improving blood sugar control and supporting weight loss
Two pharmacokinetics study of oral semaglutide in subjects with renal or hepatic impairment provided crucial information related to safety, tolerability, and dose-adjustment in such populations
Its important to remember that your A1C (if you have diabetes) is just an average measurement of your blood sugar over a few months
Another recommends 2.33mg
Genetic variants in GLP1R, GIPR, and MC4R pathways influence appetite signaling, satiety response, and metabolic efficiency